Nanotechnology Now

Our NanoNews Digest Sponsors





Heifer International

Wikipedia Affiliate Button


android tablet pc

Home > Press > CEA-Leti Joins 14 Partners in Horizon 2020 Project Targeting Antibiotic-Resistant Bacteria

Abstract:
CEA-Leti has joined 14 European research centers and private companies in a project to defeat multidrug-resistant tuberculosis (MDR TB) and methicillin-resistant staphylococcus aureus (MRSA).

CEA-Leti Joins 14 Partners in Horizon 2020 Project Targeting Antibiotic-Resistant Bacteria

Grenoble, France | Posted on June 19th, 2014

The NAREB project, which stands for Nanotherapeutics for Antibiotic Resistant Emerging Bacterial pathogens, will focus on the design, preparation and optimization of several nanoformulations of current antibiotics and novel antibacterial drugs to improve the treatment of both infections in European MDR TB patients. Specific project goals include:

- selecting antibacterial molecules and designing nanocarriers with strong antibacterial activity

- in vitro and in vivo testing of the best therapeutic combinations, including innovative genomic and bioimaging approaches

- assessing safety, regulatory and production (GLP/GMP) aspects for the most promising nanoformulations, and

- establishing a clinical development plan for preparatory work for the subsequent clinical testing of the selected nanoformulations.

The World Health Organization (WHO) has recognized antibiotic resistance as one of the three major threats to global health, and is predicting a forthcoming disaster due to the rapid, unchecked increase in antimicrobial resistance largely as a consequence of the paucity of new classes of antibacterials in development.

In the NAREB project, Leti is leading the work package for the design of new nanotherapeutics, i.e. nanoparticles enabling targeted delivery of antimicrobial agents directly into infected tissues. Leti will test its Lipidots® delivery technology for this purpose. Lipidots® delivery technology is based on biocompatible lipid nano-droplets initially developed for in vivo imaging applications.

The success of the utilization of nanoparticles in the improvement of drug targeting in other diseases opens the way for novel applications in nanotechnology-based treatments aimed at controlling MDR TB and MRSA. NAREB results will contribute to the improvement of the:

- application of nanotechnology in medicine and the development of new therapy for bacterial infectious diseases, directly benefiting EU citizens

- competitiveness of the European healthcare sector through novel systems and therapies

- cooperation and collaboration between organizations from the public and private sectors, with transfer of knowledge in regulatory issues related to the product-development pathway of nanotherapeutics used in humans.

Project team members include academic research institutes, clinical teams, biotechnology and pharmaceutical companies from eight EU countries. Supported by the European Commission under Horizon 2020 and the 7th Framework Programme, the four-year, €9.7-million project is coordinated by Institut Pasteur, Paris.

####

About CEA-Leti
By creating innovation and transferring it to industry, Leti is the bridge between basic research and production of micro- and nanotechnologies that improve the lives of people around the world. Backed by its portfolio of 2,200 patents, Leti partners with large industrials, SMEs and startups to tailor advanced solutions that strengthen their competitive positions. It has launched more than 50 startups. Its 8,000m˛ of new-generation cleanroom space feature 200mm and 300mm wafer processing of micro and nano solutions for applications ranging from space to smart devices. Leti’s staff of more than 1,700 includes 200 assignees from partner companies. Leti is based in Grenoble, France, and has offices in Silicon Valley, Calif., and Tokyo. Visit www.leti.fr for more information.

For more information, please click here

Contacts:
CEA-Leti
+33 4 38 78 02 26


Agency
+33 6 64 52 81 10

Copyright © CEA-Leti

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Measuring the Smallest Magnets July 28th, 2014

WITec to host the 11th Confocal Raman Imaging Symposium from September 29th - October 1st in Ulm, Germany July 28th, 2014

FEI adds Phase Plate Technology and Titan Halo TEM to its Structural Biology Product Portfolio: New solutions provide the high-quality imaging and contrast necessary to analyze the 3D structure of molecules and molecular complexes July 28th, 2014

Production of Toxic Gas Sensor Based on Nanorods July 28th, 2014

Nanomedicine

FEI adds Phase Plate Technology and Titan Halo TEM to its Structural Biology Product Portfolio: New solutions provide the high-quality imaging and contrast necessary to analyze the 3D structure of molecules and molecular complexes July 28th, 2014

New imaging agent provides better picture of the gut July 25th, 2014

Scientists Test Nanoparticle "Alarm Clock" to Awaken Immune Systems Put to Sleep by Cancer July 25th, 2014

Researchers create vaccine for dust-mite allergies Main Page Content: Vaccine reduced lung inflammation to allergens in lab and animal tests July 22nd, 2014

Announcements

Measuring the Smallest Magnets July 28th, 2014

WITec to host the 11th Confocal Raman Imaging Symposium from September 29th - October 1st in Ulm, Germany July 28th, 2014

FEI adds Phase Plate Technology and Titan Halo TEM to its Structural Biology Product Portfolio: New solutions provide the high-quality imaging and contrast necessary to analyze the 3D structure of molecules and molecular complexes July 28th, 2014

Production of Toxic Gas Sensor Based on Nanorods July 28th, 2014

Alliances/Partnerships/Distributorships

A*STAR and industry form S$200M semiconductor R&D July 25th, 2014

Organometallics welcomes new editor-in-chief: Paul Chirik, Ph.D. July 22nd, 2014

Haydale and Goodfellow Announce Major Distribution Agreement for Functionalised Graphene Materials July 21st, 2014

SentiMag® Now Available in Australia and New Zealand July 21st, 2014

Research partnerships

Breakthrough laser experiment reveals liquid-like motion of atoms in an ultra-cold cluster: University of Leicester research team unlocks insights into creation of new nano-materials July 25th, 2014

A*STAR and industry form S$200M semiconductor R&D July 25th, 2014

A Crystal Wedding in the Nanocosmos July 23rd, 2014

Penn Study: Understanding Graphene’s Electrical Properties on an Atomic Level July 22nd, 2014

NanoNews-Digest
The latest news from around the world, FREE



  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More














ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project







© Copyright 1999-2014 7th Wave, Inc. All Rights Reserved PRIVACY POLICY :: CONTACT US :: STATS :: SITE MAP :: ADVERTISE